Free Trial
Want deep insights into your competitors & competitive landscape? Try Patsnap Eureka!

Top 20 Key Players companies in Orally disintegrating tablet
by Highest Patent Value in the United States in 2021

The Orally disintegrating tablet top 20 is Discovery PatSnap’ annual ranking of the top 20 Highest Patent Value Orally disintegrating tablet Key Players in the United States. Discovery has identified the top key players, startups & unicorns, fast-growings, news entrants in 2021, ranking from differnt perspectives, including patent filing intensity, academic research capability, news media heat. The company list is generated from various data types.
An orally disintegrating tablet or orally dissolving tablet (ODT) is a drug dosage form available for a limited range of over-the-counter (OTC) and prescription medications. ODTs differ from traditional tablets in that they are designed to be dissolved on the tongue rather than swallowed whole. The ODT serves as an alternative dosage form for patients who experience dysphagia (difficulty in swallowing) or for where compliance is a known issue and therefore an easier dosage form to take ensures that medication is taken. Common among all age groups, dysphagia is observed in about 35% of the general population, as well as up to 60% of the elderly institutionalized population and 18-22% of all patients in long-term care facilities ODTs may have a faster onset of effect than tablets or capsules, and have the convenience of a tablet that can be taken without water. During the last decade, ODTs have become available in a variety of therapeutic markets, both OTC and by prescription.
#
Company Name
Region
Tech Topics
Total
1
Health care,Biopharmaceutical,Drug,
...[+2]
Avg patent value: 4.71 M
2
Personal Care Product,Medicine,Health care,
...[+2]
Avg patent value: 4.26 M
3
Avg patent value: 3.44 M
4
Avg patent value: 3.00 M
5
Avg patent value: 1.79 M
6
Avg patent value: 1.32 M
7
Avg patent value: 680,000
8
Franchise agreement
Avg patent value: 610,000
9
Avg patent value: 290,000
10
Avg patent value: 130,000
11
Medicine,Health care,Obesity,
...[+2]
Avg patent value: 110,000
12
Biology,Medicine,Health care,
...[+2]
Avg patent value: 87,000
13
Health care,Repaglinide,Risedronate Sodium,
...[+2]
Avg patent value: 87,000
14
Insignis Therapeutics, Inc.
Avg patent value: 37,000
15
Generic drug,Health care,Clinical trial,
...[+2]
Avg patent value: 18,000
16
Medicine,Health care,Drug,
...[+2]
Avg patent value: 3,900
17
Avg patent value: 0
18
Health care,Biopharmaceutical,TUMOR NECROSIS FACTOR BLOCKER,
...[+2]
Avg patent value: 0
19
Avg patent value: 0
20
Trade partner,Corporate social responsibility,Medicine,
...[+2]
Avg patent value: 0
Page generation time: May 13 2025